Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Fidaxomicine en vancomycine verlagen 'C. difficile'-uitscheiding en contaminatie van de omgeving
aug 2022 | Bacteriële infecties